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Quantitative proteomic 
characterization of cellular 
pathways associated with altered 
insulin sensitivity in skeletal muscle 
following high-fat diet feeding and 
exercise training
Maximilian Kleinert1,2,3,4, Benjamin L. Parker5, Thomas E. Jensen1, Steffen H. Raun1, 
Phung Pham2, Xiuqing Han1, David E. James5, Erik A. Richter 1 & Lykke Sylow  1
Regular exercise elicits advantageous metabolic adaptations in skeletal muscle, such as improved 
insulin sensitivity. However, the underpinning molecular mechanisms and the effect of diet on muscle 
exercise training benefits are unclear. We therefore characterized the skeletal muscle proteome 
following exercise training (ET) in mice fed chow or high-fat diet (HFD). ET increased exercise 
performance, lowered body-weight, decreased fat mass and improved muscle insulin action in chow- 
and HFD-fed mice. At the molecular level, ET regulated 170 muscle proteins in chow-fed mice, but only 
29 proteins in HFD-fed mice. HFD per se altered 56 proteins, most of which were regulated in a similar 
direction by ET. To identify proteins that might have particular health-related bearing on skeletal muscle 
metabolism, we filtered for differentially regulated proteins in response to ET and HFD. This yielded 
15 proteins, including the major urinary protein 1 (MUP1), which was the protein most decreased after 
HFD, but increased with ET. The ET-induced Mup1 expression was absent in mouse muscle lacking 
functional AMPK. MUP1 also potentiated insulin-stimulated GLUT4 translocation in cultured muscle 
cells. Collectively, we provide a resource of ET-regulated proteins in insulin-sensitive and insulin-
resistant skeletal muscle. The identification of MUP1 as a diet-, ET- and AMPK-regulated skeletal muscle 
protein that improves insulin sensitivity in muscle cells demonstrates the usefulness of these data.
Regular exercise has beneficial effects on most organs of the body1 and current public health organizations pro-
mote exercise as a cornerstone in prevention, management, and treatment of numerous chronic conditions, 
including hypertension, obesity, coronary heart disease, type 2 diabetes mellitus, and age-related muscle wast-
ing2. The mechanisms underpinning these benefits are complex. Notably, adaptations in exercised skeletal muscle 
play a key role in locomotion, exercise performance, metabolic responses and regulation of whole body meta-
bolic homeostasis3. Skeletal muscle comprises ∼40% of total body mass and accounts for ∼30% of the resting 
metabolic rate in adult humans4. Importantly, it is also the predominant (∼80%) site of glucose disposal under 
insulin-stimulated conditions5. Accordingly, it is not surprising that insulin-resistant muscle represents a major 
challenge to maintaining healthy glycaemia and thus is a risk factor for developing diabetes. Exercise improves 
insulin sensitivity of skeletal muscle, which translates to whole-body glycemic benefits6,7. This beneficial effect of 
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exercise is recognized in the treatment and prevention of type 2 diabetes, since exercise is often more successful 
than pharmacological interventions8.
Some key exercise signaling proteins have been identified. For example, the 5′ AMP-activated protein kinase 
(AMPK) has been shown to be an essential signaling nexus for exercise-induced increase in insulin sensitivity9,10, 
while the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is important for mito-
chondrial biogenesis11,12. Notwithstanding these important discoveries, recent studies have demonstrated that the 
signaling response to an acute exercise bout is far more complex than previously assumed13–16. Whether changes 
in the protein landscape following chronic exercise are equally dramatic is relatively unknown. Identifying the 
molecular mechanisms underlying improved insulin sensitivity following exercise training could provide novel 
therapeutic targets to treat insulin-resistant and type-2 diabetics.
In rodents, a high-fat diet can lead to obesity and insulin resistance and thus represents a model for the human 
metabolic syndrome17, an established risk factor for development of type 2 diabetes. Therefore, amelioration of 
insulin resistance by physical activity might be particularly relevant in conditions of obesity and insulin resist-
ance. Furthermore, the current obesity crisis can in part be attributed to a pervasive availability of palatable, 
calorie-dense foods and the composition of the diet consumed during training influences both enzymatic adapta-
tions and improvement in exercise performance18,19. This makes it relevant to understand how ET interacts with 
diet on the molecular level. Accordingly, we profiled adaptations in the skeletal muscle proteome of mice after 20 
weeks of ET and exposure to either chow or HFD. Both ET and HFD increase the lipid oxidative capacity in skel-
etal muscle20–22. However, adaptations in lipid oxidative capacity are unlikely candidates for the specific beneficial 
effects of exercise, since only ET-, not HFD-induced lipid adaptations promote health benefits. A side-by-side 
comparison of the ET- and the HFD-controlled proteome can identify proteins that are differentially regulated 
by HFD and ET, thereby generating a unique list of candidate proteins that could have particular health-related 
bearing on skeletal muscle metabolism.
Results
Sedentary (SED) and ET mice were fed either chow or HFD for 20 weeks. SED mice fed a HFD were ∼25% heav-
ier compared to SED chow-fed mice (Fig. 1A). Both ET groups ran the same distance per day (∼6 km/day) (data 
not shown). ET lowered body weight in both diet groups (−7%) (Fig. 1A). Fat mass accounted for ∼40% of body 
mass in HFD-fed mice and for 12% in chow-fed mice (Fig. 1B). ET reduced fat mass and increased lean body 
mass in both diet groups (Fig. 1B,C). Maximal running speed increased with ET, independent of diet (+17%) 
(Fig. 1D). HFD decreased insulin action in muscle and importantly, ET increased in vivo insulin-stimulated 
glucose uptake into skeletal muscle in both diet groups (Fig. 1E), demonstrating a clear benefit of ET on muscle 
insulin action irrespective of diet.
Proteomic analysis of gastrocnemius muscles identified 2,884 proteins at a 1% peptide and protein false dis-
covery rate (FDR) with 2,391 proteins quantified in at least two biological replicates (Supplemental Table 1). 
ET in chow-fed mice altered 170 skeletal muscle proteins compared to SED chow-fed animals (q < 0.05 and 
fold-change +/−50%). Of those, 146 were up- and 24 down-regulated (Fig. 2A). Among these regulated proteins 
were known ET-responsive proteins, like GLUT4 (+90%) and hexokinase II (HKII; +50%) (Fig. 3). Significantly 
enriched gene ontology (GO) biological terms in ET chow-fed mice were dominated by biological functions 
related to fatty acid metabolism, oxidative phosphorylation, and mitochondrial adaptations (Fig. 2D). HFD 
altered the abundance of 56 proteins (39 up- and 17 down-regulated) compared to SED chow-fed mice (q < 0.05 
and fold-change +/−50%) (Fig. 2B). Significantly enriched GO biological terms for the HFD-regulated proteins 
implicated changes in lipid metabolism pathways (Fig. 2D). ET during HFD feeding (ET on HFD) altered only 29 
proteins (20 up- and 9 down-regulated) compared to SED HFD-fed controls (Fig. 2C) and the only significantly 
enriched GO biological term for ET on HFD was fatty acid metabolism (Fig. 2D).
There was a considerable overlap between the proteins regulated by HFD and by ET, as ET altered 26 of 
the 56 proteins altered by HFD in the same direction (Fig. 2E, Fig. 4A). For example, PDK4, which promotes 
FA oxidation by inhibiting the PDH-mediated conversion of glycolysis-derived pyruvate into acetyl-CoA23, was 
increased with both HFD and ET (Fig. 3). PDK4 is often considered a key regulator of metabolic flexibility allow-
ing the muscle to quickly adjust to different fuel sources, like fatty acids (FAs) and glucose (reviewed in24). FABP3, 
which is involved in intracellular fatty acid transport25, was also increased with both HFD and ET (Fig. 3). These 
changes in PDK4 and FABP3 protein abundance are consistent with several studies showing that both exercise 
and HFD feeding increase fatty acid metabolic capacity20,21. This similarity is also evident in the GO terms, as the 
three biological pathways enriched in the HFD-regulated proteome (lipid metabolism, FA metabolism, and FA 
beta-oxidation) were enriched to a similar extent with ET (Fig. 2D).
These commonalities help explain why ET resulted in fewer regulated proteins during a HFD (compared to 
SED HFD mice). This makes the 29 proteins regulated by ET on HFD particularly interesting, because these are 
associated with improvements in insulin sensitivity based on enhanced insulin action in muscle (Fig. 1E) and 
their regulation by ET is likely independent of HFD-related processes. In addition, given the considerable overlap 
of HFD- and ET-regulated proteins, we surmised that the proteins underpinning the detrimental effects of HFD 
or, conversely, the beneficial effects of ET are the ones differentially regulated by HFD and ET. Such divergently 
regulated proteins would correlate with impaired and improved insulin sensitivity, making a causal relationship 
more likely, albeit not definite.
To this end, we sought to identify candidate proteins underpinning the exercise benefit (e.g. improved insulin 
sensitivity) by filtering for proteins that were either regulated by ET irrespective of diet or that were differentially 
regulated by HFD and ET (i.e. down with HFD but up with ET, or vice versa). This yielded 15 proteins (Fig. 4B). 
We tested proteins for which already validated antibodies were available and found that protein abundance of 
Myoglobin (MB), SLIRP and ACOT13 all increased with ET irrespective of diet (Fig. 4D–G) confirming the pro-
teome data. The proteome data also indicated that the major urinary protein 1 (MUP1) was the most decreased 
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protein on HFD, while ET blunted this HFD effect (Fig. 4B, Fig. S1A). This was confirmed by western blotting, 
which showed a marked decrease in MUP1 on HFD, while ET increased MUP1 protein abundance (Fig. 4C). 
The detection of MUP1 protein in skeletal muscle was intriguing, because MUP1 is reported to be a liver-specific 
protein that may play a role in regulating insulin sensitivity26,27. A possible explanation is that we had detected 
liver-secreted MUP1 taken up from the circulation by skeletal muscle. However, Mup1 transcripts were detected 
in cultured mouse C2C12 muscle cells and in mouse quadriceps muscle (Fig. S1B), suggesting that Mup1 is 
endogenously expressed in mouse skeletal muscle. Compared to the liver, skeletal muscle Mup1 gene expression 
is substantially lower, but still robust and several magnitudes higher compared to levels of Mup1 in the hypothal-
amus (Fig. S1B,C). In line with the alterations in protein abundance, skeletal muscle Mup1 gene expression was 
10-fold lower after 20 weeks of HFD, while ET had the opposite effect, increasing Mup1 gene expression 3-fold 
and 8-fold in chow-fed and HFD-fed mice respectively (Fig. 4H).
Having found that MUP1 is an ET- and HFD-regulated protein in skeletal muscle, we next investigated upstream 
regulation. A key regulator of energy homeostasis that is activated by exercise and required for many of the 
Figure 1. Exercise training (ET) improves running performance, body composition and insulin sensitivity. 
Mice with (ET) or without (sedentary (SED)) access to running wheels were fed either a chow (CHOW) or a 
high-fat diet (HFD) for 20 weeks and body weight (A), body composition (B,C), and maximal running capacity 
(D) were determined. In vivo saline- and insulin-stimulated glucose uptake into gastrocnemius muscle was 
assessed (E) following the 20 week long experimental period. Data are means +/− SEM (n = 4–5 for A-D and 
n = 5–8 for E). *p < 0.05, **p < 0.01 and ***p < 0.001 are main effects of ET (vs. SED). ###p < 0.001, #p < 0.05 
are main effects of diet (CHOW vs HFD). $$$p < 0.001 is a main effect for insulin (Insulin vs Saline).
www.nature.com/scientificreports/
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exercise-related health benefits is AMPK28. We therefore investigated whether the increased Mup1 expression with 
ET requires functional AMPK by measuring Mup1 gene expression in skeletal muscle from SED and ET wildtype 
(WT) or transgenic mice overexpressing an AMPKα2 kinase dead (AMPK KD) construct in striated muscle29. 
AMPK KD mice exhibit a reduced running capacity, but with ET both WT and AMPK KD mice can adapt to ET 
and improve their running capacity to similar extent30. In SED WT and SED AMPK KD mice, Mup1 expression 
was similar (Fig. 4E). With ET, Mup1 expression increased in WT (+250%), but not in AMPK KD mice (Fig. 4E), 
suggesting that AMPK activation is required for the ET-mediated increase in skeletal muscle Mup1 gene expression.
The induction by ET, possibly via AMPK, makes MUP1 an intriguing candidate that may play a role in the 
insulin sensitizing effects of exercise. In support of the notion, a previous study reported an improved glucose tol-
erance in obese diabetic mice following pharmacological treatment with recombinant MUP127, but it is unknown 
whether this reflected improved insulin sensitivity at the level of the muscle. To understand whether MUP1 has 
a direct effect on muscle insulin sensitivity, we employed L6 muscle cells that stably overexpress a myc-tagged 
version of the insulin-responsive glucose transporter 4 (GLUT4). This allows for quantification of GLUT4 trans-
location from the inside of the cell to the membrane and this model has been widely used to investigate alterations 
in insulin sensitivity. When we pretreated these cells with recombinant MUP1 protein, basal GLUT4 transloca-
tion was increased (Fig. 5A). Furthermore, MUP1 potentiated submaximal insulin-mediated GLUT4 transloca-
tion in a dose-dependent manner, suggesting that MUP1 has direct insulin sensitizing properties in muscle cells 
(Fig. 5A). Akt signaling, AMPK activity (judged by p-ACC Ser212), and p38 phosphorylation were not altered 
by MUP1 (Fig. 5B), suggesting that these pathways do not mediate the effect of MUP1 on GLUT4 translocation.
Discussion
In the present study, we provide a unique resource of proteins regulated by exercise training (ET), high-fat diet 
(HFD), and ET during HFD in mouse skeletal muscle. This side-by-side comparison allowed us to create a list of 
candidate proteins that may be particularly relevant for transducing the beneficial metabolic adaptions of exer-
cise. The usefulness of this resource is demonstrated by the identification of MUP1 as a HFD- and ET-regulated 
skeletal muscle protein that improves insulin sensitivity in muscle cells.
In healthy insulin-sensitive individuals, 50–60% of carbohydrates in a meal are taken up by skeletal muscle31. 
With this large contribution to postprandial glucose disposal, insulin resistance of skeletal muscle5 represents a 
serious challenge to whole body glucose homeostasis. Consequently, maintaining muscle mass and metabolic 
function is essential for health. Exercise improves skeletal muscle insulin sensitivity6,7,32, making exercise an effi-
cacious treatment for type 2 diabetes mellitus and numerous other chronic conditions2. However, at the popula-
tion level, the adherence to exercise training is poor. As we are facing an unprecedented obesity crisis with serious 
comorbidities, like diabetes, deciphering the molecular blueprint that underpins the metabolic benefits of exercise 
possesses therapeutic potential.
Figure 2. Exercise training (ET)- and high-fat diet (HFD)-regulated skeletal muscle proteins. Volcano plots 
for the ET effect (ET CHOW/ SED CHOW), the HFD effect (SED HFD/ SED CHOW) and the ET during HFD 
effect (ET HFD/ SED HFD) are shown (A–C) (darker circles within each plot are significantly altered (q < 0.05 
and fold-change +/−50%). Enriched PANTHER GO-Slim Biological Process terms (D) based on the regulated 
proteins (blue, green and red font denote ET, HFD, and ET on HFD effects, respectively; the larger the font size 
the greater the log10 enrichment for the specified pathway). Venn diagram (E) of the altered proteins. SED = 
sedentary.
www.nature.com/scientificreports/
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Therefore, we characterized global protein changes in response to ET. The inclusion of HFD and ET on HFD 
groups is a major strength of this study. Both ET and HFD increase lipid oxidative capacity in skeletal muscle20,21, 
but only ET leads to health benefits, suggesting that proteins similarly regulated by ET and HFD are unlikely can-
didates to transduce the beneficial effects of exercise training. Thus, we were interested in identifying proteins that 
are differentially regulated by HFD and ET, such as MUP1, which was markedly decreased by HFD but increased 
with ET.
MUP1 belongs to the lipocalin family, which comprises a large group of small extracellular proteins with 
diverse functions. Lipocalins have been shown to bind and transport small hydrophobic molecules as well as 
soluble macromolecules and some lipocalins bind to specific cell-surface receptors33. For example, lipocalin 2, 
secreted from bone, is thought to act on the melanocortin 4 receptor (MC4R) in the hypothalamus to reduce 
appetite34. MUP1 is thought to be predominantly expressed in and secreted from the liver and circulating MUP1 
levels are decreased in mouse models of obesity26,27. Pharmacologically restoring MUP1 levels in male obese db/
db mice improves whole body insulin sensitivity27. How this is mediated by MUP1 and on what organs MUP1 
is acting is unknown. Our data indicate that MUP1 is expressed in skeletal muscle, and, akin to the circulating 
MUP1 levels, protein abundance is down-regulated in obesity. Interestingly, we show that MUP1 improves insu-
lin sensitivity of GLUT4 translocation in cultured muscle cells, but it is unclear if this is mediated via specific 
receptors or if MUP1 is taken up by the muscle to trigger signaling events inside the cell. Our signaling data 
appear to rule out MUP-1 effects on Akt, AMPK and p38, which all have been implicated in the regulation of 
GLUT4 translocation in muscle35. Alternatively, MUP1 could also act as a binding partner that is required for 
other proteins to function. We also found that the ET-dependent induction of Mup1 gene expression required 
Figure 3. Metabolic pathways and protein groups regulated by exercise training (ET) and high-fat diet (HFD). 
Different proteins belonging to outlined cellular pathways or protein groups. Data are log2 fold changes of the 
indicated ratios +/− SEM (E-I). *q < 0.05 for the ratio. SED = sedentary; InsR = insulin receptor.
www.nature.com/scientificreports/
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Figure 4. MUP1 is regulated by high-fat diet (HFD) and exercise training (ET). Heatmaps (A) of proteins 
altered (q < 0.05 and fold-change +/−50%) by ET on Chow (top), HFD (middle), or ET on HFD (bottom 
heatmap) with corresponding proteins from the other groups. Proteins depicted in (B) were either altered in 
the same direction by ET and ET on HFD, or they were oppositely altered by HFD and ET on Chow or ET on 
HFD (‘+’ denotes increased, ‘−’ decreased abundance; a diagonal strikethrough means that the protein was not 
significantly regulated). Quantification and representative images of western blot performed for the indicated 
proteins (C–G, n = 5–10). The effects of ET and HFD on Mup1 gene expression in muscle (H, n = 7–10), as 
well as the effect of ET effect on Mup1 gene expression in AMPK KD mice (I, n = 8). Data are means +/− 
SEM. ***p < 0.001 main effect of diet (HFD vs Chow). ###p < 0.001 and ##p < 0.01 main effects for activity (ET 
vs sedentary (SED)). ¤¤p < 0.01 difference between indicated groups.
www.nature.com/scientificreports/
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functional AMPK. Since AMPK is not necessary for Mup1 expression in the sedentary state, it is most likely 
that AMPK-specific pathways activated with exercise regulate Mup1 expression, but the details of this regulation 
remain to be unraveled.
In addition to MUP1, two other hits stand out to us. One is the SRA Stem-Loop Interacting RNA Binding 
Protein (SLIRP), which has recently been identified as a novel regulator of mitochondrial protein translation36. In 
our study, SLIRP was increased with both ET and ET on HFD, while HFD alone had no effect on SLIRP protein 
abundance. This leads to the intriguing hypothesis that mitochondrial adaptations and possibly improvements 
in exercise performance with ET are in part regulated by SLIRP. Another intriguing hit is the guanylate binding 
protein 4 (GBP4), which was increased with HFD whereas both ET and ET during HFD decreased GBP4 protein. 
GBPs are thought to play a role in the innate immune response and their expression is generally increased by 
pro-inflammatory stimuli37. Thus the expression pattern may reflect an HFD-mediated inflammatory state that 
can be ameliorated by ET. Whether genetic downregulation of the protein would confer metabolic protection 
during HFD feeding in skeletal muscle would be an interesting hypothesis to test.
A limitation of our findings is the use of an animal model. Although there is considerable overlap between 
humans and mice in metabolic processes and regulation thereof, there are also considerable distinctions, such as 
the vast difference in metabolic rate between mice and humans17. Therefore, it remains to be seen whether exer-
cise and diet regulate the same proteins and whether these proteins in turn regulate distinct metabolic processes 
in human skeletal muscle. This, however, can now be addressed following our contribution in targeted hypothesis 
driven follow-up studies.
In conclusion, since obesogenic HFD and exercise training have opposite impact on health, we believe that 
proteins that are differentially regulated by exercise training and HFD are particularly promising candidate pro-
teins to transduce exercise-induced health benefits. This rationale is supported by the identification of MUP1 
as a novel diet-, ET- and AMPK-regulated skeletal muscle protein that improves insulin sensitivity of GLUT4 
translocation in muscle cell culture. This warrants future investigations into MUP1 and also into the other unique 
molecular targets we have provided.
Methods
Animals. Female C57BL/6J (Taconic) mice with or without access to running wheels received standard chow 
diet (Altromin No. 1324; Brogaarden, Denmark), or 60% high-fat diet (HFD) (D12492; Brogaarden, Denmark) 
and water ad libitum. Mice, 9 weeks old at the start of the 20 weeks intervention, were single-housed on a 12:12-h 
light-dark cycle at 21–22 degrees Celsius. The Danish Animal Experimental Inspectorate approved all exper-
iments and all experiments were performed in accordance with relevant guidelines and regulations. For the 
AMPK KD and wild-type mice, information on animal care and experimental design can be found here30.
In vivo 2-deoxy-glucose (2DG) uptake experiments. Mice were fasted for 3–5 hour from 7 AM and 
anaesthetized with pentobarbital (i.p. injection of 7.5/9.5 mg (for chow/HFD-fed mice) pentobarbital sodium per 
100 g body weight). A bolus of saline containing 66.7 μCi/ml [3H]2DG (Perkin Elmer) corresponding to ∼9 μCi/
mouse (6 μl/g body weight) was injected retro-orbitally. In addition, the injectate contained either 0.5U/kg body 
weight insulin (Actrapid, Novo Nordisk, Bagsværd, Denmark) or a comparable volume of saline as in38. Blood 
was collected from the tail vein before and 5 and 10 min after the injection. At the same time, a drop of blood was 
used to measure glucose concentration with a handheld glucometer (Bayer Contour, Switzerland). Specific 2-[3H]
DG tracer activity was analyzed in the 10 min blood sample. After 10 min mice were killed by cervical dislocation 
and gastrocnemius muscle were excised, snap-frozen in liquid nitrogen and stored at −80 °C. 2DG uptake was 
analyzed as described before39.
Figure 5. MUP1 augments insulin-stimulated GLUT4 translocation in cultured muscle cells. Insulin-
stimulated (10 nM) GLUT4 translocation (A) and signaling (B) was assessed in L6-mycGLUT4 myoblasts 
in presence of the indicated concentrations of recombinant MUP1 protein. In A data are means +/− SEM. 
***p < 0.001 and *p < 0.05 different from 0 µg/ml within Basal or Insulin. ###p < 0.001 differences between 
indicated groups. In B, representative results of three independent experiments are shown.
www.nature.com/scientificreports/
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Body composition analysis. Fat mass and lean body mass were determined with an Echo MRI scanner 18 
weeks into the 20-week intervention.
Proteomic analysis. Quantitative proteomics was performed on a total of 18 mouse gastrocnemius muscle 
samples from; (i) chow sedentary (n = 4), (ii) chow training (n = 4), (iii) HFD sedentary (n = 5), and iv) HFD 
training (n = 5). Muscles were lysed in 6 M urea, 2 M thiourea, 0.1% SDS in 50 mM triethylammonium bicarbo-
nate (TEAB) pH 8.0 containing a protease and phosphatase inhibitor cocktail (Roche) using tip-probe sonication. 
The lysates were centrifuged at 16,000 × g for 10 min and protein precipitated with 5 volumes of acetone overnight 
at −30 °C. The precipitated proteins were resuspended in 6 M urea, 2 M thiourea in 50 mM TEAB pH 8.0 and 
100 µg of protein normalised to a final volume of 40 µL. The proteins were reduced with 10 mM dithiothreitol 
(DTT) for 60 min at room temperature followed by 25 mM iodoacetamide for 30 min at room temperature in 
the dark. The reactions were quenched to a final concentration of 20 mM DTT and digested with 2 µg of Lys-C at 
room temperature for 2 h. The digest was diluted with 5 volumes of 50 mM TEAB pH 8.0 and digested with 2 µg 
of trypsin overnight at 37 °C. The digest was acidified to a final concentration of 2% formic acid and centrifuged 
at 16,000 × g for 10 min. Peptides were desalted with hydrophilic-lipophilic solid phase extraction (HLB-SPE; 
Waters) followed by elution with 50% acetonitrile containing 0.1% trifluoroacetic acid (TFA) and dried by vac-
uum centrifugation. Peptides were resuspended in 25 µL of 500 mM TEAB pH 8.3 and normalised to 10 µg in 
8 µL. Peptides were labelled by adding 0.1 mg TMT reagent in 8 µL of acetonitrile and incubated at room temper-
ature for 90 min. The reactions were quenched with 1 µL of 5% hydroxylamine and 150 µL of 0.1% TFA followed 
by pooling of the peptides to result in two multiplexed experiments which were desalted with HLB-SPE. Each 
experiment was fractionated into 12 fractions using hydrophilic interaction liquid chromatography as previously 
described40.
Each fraction was analysed on a Dionex 3500RS nanoUHPLC coupled to an Orbitrap Fusion mass spectrom-
eter with Tune v1.2.1149 in positive mode. Peptides were separated using an in-house packed 75 μm × 40 cm 
pulled column (1.9 μm particle size, C18AQ; Dr Maisch, Germany) with a gradient of 2–30% MeCN containing 
0.1% FA over 120 min at 250 nl/min at 55 °C. An MS1 scan was acquired from 375–1575 m/z (120,000 resolution, 
4e5 AGC, 100 ms injection time) followed by MS2 data-dependent acquisition of the 12 most intense precursor 
ions with CID and detection in the ion trap (2e4 AGC, 70 ms injection time, 35 NCE, 2.0 m/z quadrupole isola-
tion width, 0.25 activation Q). To quantify TMT reporter ions, a synchronous precursor selection MS3 scan was 
performed on the 10 most abundant fragment ions with HCD and detection in the orbitrap (100–500 m/z, 1e5 
AGC, 120 ms injection time, 55 NCE, 2.0 m/z isolation width)41.
Analysis of mass spectrometry data. All raw data were processed with Proteome Discoverer v2.1.0.81 
and searched against the mouse UniProt database using SequestHT. The MS1 tolerance was set to 20 ppm and the 
MS2 mass tolerance set to 0.6 Da. Peptides were searched with a maximum of 2 miss cleavages with oxidation of 
methionine set as a variable modification and, carbamidomethylation of cysteine and TMT labelling of peptide 
N-terminus/lysine set as fixed modifications. All data was filtered to a 1% peptide spectral match (PSM) FDR and 
protein FDR using percolator. Protein identification and quantification was performed with a minimum of one 
peptide. Reporter ion quantification was performed using 20 ppm and, PSMs filtered for a signal-to-noise greater 
than 10 and a maximum co-isolation threshold of 50%. Statistical analysis was performed in Perseus software and 
differentially regulated proteins calculated using t-tests corrected for multiple testing with Benjamini Hochberg 
adjustment. Significantly regulated proteins were defined with an adjusted p, q < 0.05 and fold-change +/−50%.
Gene ontology (GO) term enrichment analysis. Gene names of significantly regulated proteins 
(q < 0.05 and fold-change of +/−50%) were submitted to a PANTHER Overrepresentation Test online (http://
www.pantherdb.org) using the PANTHER version 13.0 (released 2017-11-12) with a FISHER test type and a Mus 
musculus reference list. Over-presented PANTHER GO-Slim Biological Process terms with a false discovery rate 
of less than one percent on a log10 enrichment of >0.5 are shown as relative font sizes.
Preparation of RNA and gene expression analysis. Total RNA from tissues was prepared using 
RNeasy Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. cDNA synthesis was per-
formed with a QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
instructions. Gene expression was profiled with SYBR Green based quantitative PCR (qPCR), using the 7900HT 
Fast Real-Time PCR System (Thermo Fisher Scientific, Erlangen, Germany). The relative expression levels of 
each gene were normalized to the housekeeping gene hypoxanthine phosphoribosyltransferase (Hprt) using the 
ddCt method. The following primers were used: Mup1 forward 5′-GAAGCTAGTTCTACGGGAAGGA-3′, Mup1 
reverse 5′-AGGCCAGGATAATAGTATGCCA-3′ and Hprt forward: 5′-AAGCTTGCTGGTGAAAAGGA-3′, 
Hprt reverse 5′-TTGCGCTCATCTTAGGCTTT-3′. Primer efficiency was tested.
MUP1 treatment and GLUT4 translocation in L6 cells. L6 myoblasts stably over-expressing GLUT4 
with a c-myc epitope tag (L6-GLUT4myc)42, a kind gift from Amira Klip, were grown in α-MEM media (GIBCO 
#1257-063) with 10% fetal bovine serum (GIBCO #26140-038), 100 μg/mL streptomycin, 100 units/mL penicillin, 
0.25 μg/ml Fungizone© (GIBCO #15240-062) (5% CO2, 37 °C). Cells were seeded in 96 well plates and grown until 
90% confluent. Cells were incubated with the indicated concentrations of recombinant MUP1 protein (Abcam; 
Cat# ab95193) for 24 hours. For analysis of GLUT4 translocation, cells were serum starved for 4 hours and stim-
ulated with insulin (10 minutes, submaximal dose of 10 nM) or not stimulated. Immediately following stimula-
tions, cells were chilled on ice, fixed with 3% paraformaldehyde, blocked in 5% goat serum, and incubated with 
primary anti-myc antibody (Cell Signaling Technology). The signal was detected with a secondary HRP-antibody 
and o-Phenylenediamine reagent (Sigma–Aldrich) was added to each well to initiate a color reaction with the 
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secondary antibody. This was terminated with 5 M HCl, before absorbance at 492 nm was measured. Background 
absorbance (no primary antibody) was subtracted. The experiment was performed twice.
For the signaling experiment, cells were treated exactly as above, except that cells were seeded in 12-well 
plates and at the end of insulin stimulation cells were lysed for western blotting. The signaling experiment was 
performed three times and a representative experiment is shown in the manuscript.
Western Blotting. Muscles were pulverized in liquid nitrogen and homogenized 2 × 0.5 min at 30 Hz using 
a Tissuelyser II bead mill (Qiagen, USA) in ice-cold homogenization buffer (10% Glycerol, 20 mM 
Na-pyrophosphate, 150 mM NaCl, 50 mM HEPES (pH 7.5), 1% NP-40, 20 mM β-glycerophosphate, 10 mM NaF, 
2 mM PMSF, 1 mM EDTA (pH 8.0), 1 mM, EGTA (pH 8.0), 10 μg/ml Aprotinin, 10 μg/ml Leupeptin, 2 mM 
Na3VO4, 3 mM Benzamidine, 5 mM Nicotinamide). Homogenates were rotated end-over-end for 1 h at 4 °C, and 
cleared by centrifugation at 10000 × g for 20 min at 4 °C. Cells were washed once with ice-cold PBS, quickly dried, 
and scraped off in presence of 150 μl ice-cold RIPA Buffer (SIGMA, Cat# R0278) with protease and phosphatase 
inhibitor (ThermoFisher, Cat# 78446). Cells were rigorously pipetted up and down 10 times and then centrifuged 
at 13000 × g for 10 min at 4 °C. Muscle and cell lysate protein content was determined by bicinchoninic acid 
method and lysates were diluted to the same protein concentration. Total protein and phosphorylation levels of 
indicated proteins were determined by standard immunoblotting, loading equal amounts of protein. The follow-
ing antibodies were used:
Statistical analysis of non-proteome data. Results are shown means ± SEM. Statistical testing was per-
formed using paired t-tests or one- or two-way ANOVA (repeated or non repeated measurements) as appropriate. 
Tukey’s post hoc test was performed when ANOVA revealed significant interaction. The significance level was 
set at p < 0.05.
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